Medical News

---

• FeNO measurement distinguishes children with allergic sensitization
• Nonhepatic insulin resistance may be involved in hypertension pathogenesis
• Nonhepatic insulin resistance may be involved in hypertension pathogenesis
• Cancer risk reduced in schizophrenia patients
• Psoriasis makes hypertension harder to control
• Baroreflex activation therapy promising for resistant hypertension
• Children with ADHD at increased risk for bipolar disorder
• Specific metabolic abnormalities associated with schizophrenia
• Candesartan, amlodipine offer similar benefits for paroxysmal AF with hypertension
• Valsartan beats amlodipine for CHF risk, but not CV events, in hypertensive diabetics
• Valsartan beats amlodipine for CHF risk, but not CV events, in hypertensive diabetics
• Work, social, or family life disability affects half of bipolar patients
• Reduced visual contrast sensitivity in SPD patients
• Hippocampal interneuron alterations evident in bipolar patients
• Valence influences odor identification in schizophrenia patients
• Stigma linked to functioning in bipolar disorder patients

FeNO measurement distinguishes children with allergic sensitization Posted: 10 Apr 2011 05:00 PM PDT Results from a Taiwanese study suggest that fraction of exhaled nitric oxide measurement effectively distinguishes children with allergic sensitization from children without, regardless of allergic symptoms.

Nonhepatic insulin resistance may be involved in hypertension pathogenesis Posted: 10 Apr 2011 05:00 PM PDT Japanese researchers report that an insulin sensitivity index based on whole body insulin resistance predicts the development of hypertension more accurately than an index that reflects hepatic insulin resistance alone.

Nonhepatic insulin resistance may be involved in hypertension pathogenesis Posted: 10 Apr 2011 05:00 PM PDT Japanese researchers report that an insulin sensitivity index based on whole body insulin resistance predicts the development of hypertension more accurately than an index that reflects hepatic insulin resistance alone.

Cancer risk reduced in schizophrenia patients Posted: 07 Apr 2011 05:00 PM PDT Results from a Taiwanese study suggest that patients with schizophrenia are less likely to develop most types of cancer than individuals without the mental health disorder.

Psoriasis makes hypertension harder to control Posted: 07 Apr 2011 05:00 PM PDT Study results show that hypertension is less easily controlled in patients who also have psoriasis compared with non-psoriatic hypertensive patients.

Baroreflex activation therapy promising for resistant hypertension Posted: 07 Apr 2011 05:00 PM PDT Baroreflex activation therapy may be a promising new approach in patients with resistant hypertension, the Rheos pivotal trial suggests.

Children with ADHD at increased risk for bipolar disorder Posted: 07 Apr 2011 05:00 PM PDT Children with attention-deficit hyperactivity disorder are at increased risk for developing bipolar disorder, suggest results from an Italian study.

Specific metabolic abnormalities associated with schizophrenia Posted: 06 Apr 2011 05:00 PM PDT Schizophrenia patients exhibit specific metabolic abnormalities related to glucoregulatory processes and proline metabolism, Finnish researchers have found.

Candesartan, amlodipine offer similar benefits for paroxysmal AF with hypertension Posted: 06 Apr 2011 05:00 PM PDT Candesartan and amlodipine offer similar anti-arrhythmic benefits for paroxysmal atrial fibrillation associated with hypertension, an open-label trial suggests.

Valsartan beats amlodipine for CHF risk, but not CV events, in hypertensive diabetics Posted: 06 Apr 2011 05:00 PM PDT The angiotensin II receptor blocker valsartan was comparable to the calcium channel blocker amlodipine at reducing blood pressure in Japanese patients with hypertension and diabetes or impaired glucose tolerance, according to results of the NAGOYA HEART study.

Valsartan beats amlodipine for CHF risk, but not CV events, in hypertensive diabetics Posted: 06 Apr 2011 05:00 PM PDT The angiotensin II receptor blocker valsartan was comparable to the calcium channel blocker amlodipine at reducing blood pressure in Japanese patients with hypertension and diabetes or impaired glucose tolerance, according to results of the NAGOYA HEART study.

Work, social, or family life disability affects half of bipolar patients Posted: 06 Apr 2011 05:00 PM PDT Results from a Spanish study suggest that more than half of bipolar disorder patients experience some degree of disability in their work, social, or family life.

Reduced visual contrast sensitivity in SPD patients Posted: 05 Apr 2011 05:00 PM PDT Results from a US study show that patients with schizotypal personality disorder have lower visual contrast sensitivity than those without the condition.

Hippocampal interneuron alterations evident in bipolar patients Posted: 05 Apr 2011 05:00 PM PDT Patients with bipolar disorder show specific hippocampal interneuron alterations relative to mentally healthy individuals, US researchers have found.

Valence influences odor identification in schizophrenia patients Posted: 04 Apr 2011 05:00 PM PDT Odor identification accuracy in patients with schizophrenia is influenced by odor valence, with patients more likely to incorrectly identify pleasant and neutral smells than unpleasant ones, researchers have found.

Stigma linked to functioning in bipolar disorder patients Posted: 04 Apr 2011 05:00 PM PDT High levels of self-reported stigma are associated with low levels of functioning in patients with bipolar disorder, study results suggest.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610